Described herein are pharmaceutical packaging programs which prevent oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-sensitive drugs, these types of units which include a syringe using an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with pretty lower permeability to o